Ce manuscrit décrit la synthèse et l'évaluation biologique d'analogues de l'ω-agatoxine IVB dans le but de trouver de nouveaux outils pour l'étude de l'activité des canaux calciques. L'ω-agatoxine IVB est une neurotoxine peptidique isolée du venin d'araignée Agelenopsis aperta qui à ce jour est l'inhibiteur spécifique et sélectif des canaux calciques voltage-dépendants de type P/Q. Ces canaux sont impliqués dans la neurotransmission dépendante du Glutamate dans le système nerveux central. La synthèse de structures peptidiques simplifiées, en comparaison avec celle de la toxine native est décrite. La méthodologie de synthèse de différents analogues cycliques de cette neurotoxine est présentée. Les composés sont synthétisés par synthèse peptidique sur phase solide en stratégie Fmoc, avec une étude particulière sur les conditions de cyclisation et le choix des groupements protecteurs appropriés. Les modifications d es peptides naturels pour obtenir de nouveaux composés biologiquement actifs incluent l'insertion d'aminoacides non naturels et de liaisons pseudopeptidiques. Les analogues synthétisés ont été testés par des méthodes d'électrophysiologie (patch clamp) et d'imagerie calcium ; les activités biologiques des peptides sont corrélées à l'aide d'analyses structurales par RMN et modélisation moléculaire. / This manuscript describes the synthesis and biological valuation of w-agatoxin IVB mimetics with the intention of finding new tools for the study of calcium channels activity. w-Agatoxin IVB is a peptide neurotoxin isolated from the venom of spider Agelenopsis aperta which is a specific and selective inhibitor of P/Q-type voltage-dependent calcium channels. These channels are involved in Glutamate-dependent neurotransmission in the central nervous system. The synthesis of structurally simplified peptides, in comparison with native toxin is described. The methodology of synthesis of different cyclic analogues of this neurotoxin is presented. The compounds were synthesized by solid phase peptide chemistry and Fmoc strategy, with particular consideration for cyclization conditions and an insight into selection of protecting groups. The modifications of the natural peptide to get new biologically active compounds included the insertion of unnatura l amino acids and pseudopeptides bonds. The synthesized analogues were tested by methods of electrophysiology (patch clamp) and calcium imagery; the biological activities of peptides are compared with the aid of structural analyses by RMN and molecular modeling.

As estruturas e propriedades biológicas das amidas piplartina e a piperina, isoladas respectivamente de Piper tuberculatum e P. nigrum, inspiraram a síntese de 89 derivados e 7 esters estruturalmente relacionadas. As preparações envolveram metodologias tradicionais e os compostos purificados tiveram suas estruturas caracterizadas por análises espectroscópicas e espectrométricas. Os estudos de fragmentação por IE e IES indicaram a clivagem preferencial da ligação N-CO no caso das cinamamidas, dienamidas e cinamimidas. Estudos computacionais envolvendo afinidade protônica e energias de ligação confirmaram a fragmentação preferencial da ligação amídica para as amidas. A citotoxicidade de 89 substâncias foi avaliada contra três células leucêmicas (K562, Nalm6 e Raji) e a partir dos valores de IC50 foram realizados estudos de relação estrutura-atividade (SAR). As linhagens K562 e a Nalm6 foram a mais resistente e vulnerável, respectivamente, e as amidas piplartina (1a), N-Ciclohexil-N-(ciclohexilcarbamoil)-3-(3,4,5-trimetoxifenil)propanamida (1n), e (E)-N,N-dibutil-3-(3,4-dimetoxifenil)acrilamida (13h) foram as mais ativas com IC50 de 0,34 µM; 0,84 µM e 1,88 µM contra K562 e (E)-N-ciclohexil-N-(ciclohexilcarbamoil)-3-(3,4-dimetoxifenil)acrylamida (13i) com IC50 de 0,98 µM contra Nalm6. A avaliação de atividade leishmanicida de 18 substâncias não se mostrou promissora. As abordagens qualitativas e quantitativas foram feitas baseadas nos descritores moleculares gerados pelo programa VolSurf+. A partir de métodos quimiométricos tais com PLS, algoritmo genético, árvores de decisão foi possível gerar modelos para correlacionar às propriedades moleculares com a atividade biológica. As propriedades de absorção, distribuição, metabolismo e excreção e os equilíbrios entres as regiões hidrofílicas e hidrofóbicas foram importantes para atividade citotóxica. O estudo de ancoragem molecular mostrou que as amidas (E)-N,N-dibutil-3-(3,4,5-trimetoxifenil)acrilamida (1l), 1n, (E)-3-(4-clorofenil)-N-ciclohexil-N-(ciclohexilcarbamoil)acrilamida (5a), 13h e 13i podem atuar como inibidores das histonas desacetilases particularmente HDAC4 e HDAC8. / The structures and biological properties of the amides piplartine and piperine isolated from Piper tuberculatum and P. nigrum respectively, inspired the synthesis of derivatives 89 and 7 esters structurally related. Their preparations were achieved using classical procedures and the purified amides were submitted to spectroscopic and spectrometric characterization. The study of fragmentation process by EI and ESI suggested the preferential cleavage of the N-CO bond of cinnamamides, dienamides and cinnamimides. The cytotoxicity of 89 compounds was evaluated against three leukemic cells (K562, Nalm6 and Raji) and based on IC50 values the structure-activity relationship (SAR) was performed. While the K562 and Nalm6 cells were the more resistant and more sensitive, respectively, the amides piplartine (1a), N-cyclohexyl-N-(ciclohexylcarbamoyl)-3-(3,4,5-trimethoxyphenyl)propanamide (1n) and (E)-N,N-dibutyl-3-(3,4-dimethoxyphenyl)acrylamide (13h) were in general the most active with IC50 of 0.34 µM, 0.84 µM and 1.88 µM against K562 and (E)-N-cyclohexyl-N-(ciclohexylcarbamoyl)-3-(3,4-dimethoxyphenyl)acrylamide (13i) with IC50 of 0.98 µM against Nalm6. The evaluation of leishmanicidal activity of 18 substances was also performed but was not promising. Qualitative and quantitative approaches were made based on molecular descriptors generated by VolSurf+ program. The chemometric methods such as PLS, genetic algorithm, decision trees generated models to correlate molecular properties with the biological activity. The absorption, distribution, metabolism and excretion properties and a balance between hydrophilic and hydrophobic moieties of the amides were important for an optimized activity. The molecular docking revealed that amides such as (E)-N,N-dibutyl-3-(3,4,5-trimethoxyphenyl)acrylamide (1l), 1n, (E)-3-(4-chlorophenyl)-N-cyclohexil-N-(cyclohexylcarbamoyl)acrylamide (5a), 13h and 13i have potential to act as possible inhibitors of histone deacetylase proteins particularly HDAC4 and HDAC8.

A hemoglobina (Hb) é uma fonte reconhecida de peptídeos com funções biológicas diversas. O fragmento 33-61 da cadeia α da Hb, isolado do trato gastrointestinal do carrapato Boophilus microplus, foi o primeiro a ser descrito com ação antimicrobiana. O seu análogo sintético amidado, Hb33-61a, mostrou-se ativo contra bactérias Gram-positivas e fungos [Fogaça et al. (1999) J. Biol. Chem. 274, 25330-4]. O estudo de análogos do Hb33-61 nas formas amidada e com carboxila livre revelou que a amidação provoca aumento significativo da atividade frente a Candida albicans. Por apresentar propriedades biológicas e estruturais idênticas às do Hb33-61a, o Hb40-61a pareceu ser a sua porção mÌnima ativa [Sforça et al. (2005) Biochemistry 44, 6440- 51; Machado et al. (2007) Biopolymers 88, 413-26]. Para comprovar tal sugestão, no presente trabalho, sintetizamos, purificamos e caracterizamos novos an·logos do Hb33-61a, bem como os avaliamos quanto às suas atividades frente a C. albicans e Micrococcus luteus. Os resultados confirmaram a sugestão apenas para a ação antifúngica. O análogo Hb40-61a também se mostrou ativo frente a C. albicans resistente a fluconazol. A sua atividade antifúngica se mostrou fortemente dependente da força iônica do meio. A sua baixa atividade hemolítica foi confirmada mesmo em meio de baixa força iônica. O peptídeo Hb40-61a não apresentou sinergismo com o fluconazol frente a C. albicans. A cinética de morte celular mostrou que ele mata a levedura de forma rápida. Portanto, esta hemocidina sintética pode apresentar valor comercial se a via de administração for tópica ou se o seu uso envolver meios de baixa força iônica. Além disso, ela é um modelo valioso para o estudo do mecanismo de ação de peptídeos antimicrobianos com características estruturais similares e pode servir de base para o desenho de novos agentes antibiôticos. / It is well known that hemoglobin (Hb) is a source of biologically active peptides. The fragment 33-61 of bovine hemoglobin α-chain, isolated from the gut contents of the tick Boophilus microplus, was the first identified with antimicrobial activity . Its amidated analogue, Hb33-61a, showed to be active against Gram-positive bacteria and fungi strains [FogaÁa et al. (1999) J. Biol. Chem. 274, 25330-4]. The study of a series of carboxyl-free and amidated synthetic analogues of Hb33-61 revealed that C-terminus amidation enhances the activity against Candida albicans. Since Hb33-61a and Hb40-61a presented identical biological and structural properties, it seemed that Hb40-61a was Hb33-61a minimal active motif [SforÁa et al. (2005) Biochemistry 44, 6440- To test this suggestion, in the present study 51; Machado et al. (2007) Biopolymers 88, 413-26]. we synthesized, purified and characterized Hb40-61a analogues and assayed them against C. albicans and Micrococcus luteus. The results confirmed the suggestion only for the antifungal activity. When tested against fluconazole-resistant C. albicans, Hb40-61a was also active. Its antifungal activity showed to be dependent on the ionic strength of the medium. Its low hemolytic activity was confirmed even under low ionic strength conditions. Hb40-61a had no synergic effect with fluconazole on C. albicans. In vitro time-kill assays demonstrated that Hb40-61a kills the yeast rapidly. Therefore, this synthetic hemocidin may be of commercial interest for topical application or other uses involving low ionic strength medium. Moreover, it can serve as a template for the study of the mechanism of action of structurally related antimicrobial peptides or for the design of novel antibiotic drugs.

Xu, Xiao-ping. / "March 1999." / Thesis (Ph.D.)--Chinese University of Hong Kong, 1999. / Includes bibliographical references (p. 152-166). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Mode of access: World Wide Web. / Abstracts in English and Chinese.

Submitted by Rosangela Silva (rosangela.silva3@unioeste.br) on 2017-08-30T20:10:51Z No. of bitstreams: 2 TAISA PEREIRA PIACENTINI RIBEIRO.pdf: 3904493 bytes, checksum: 479855c30863d881e3a40de6b85ca548 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) / Made available in DSpace on 2017-08-30T20:10:51Z (GMT). No. of bitstreams: 2 TAISA PEREIRA PIACENTINI RIBEIRO.pdf: 3904493 bytes, checksum: 479855c30863d881e3a40de6b85ca548 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Previous issue date: 2017-02-09 / The search for new herbicides to control herbicides-resistant weeds is necessary to attend the rising demand of food from the world’s population. This work was divided into two parts. The first aimed to obtain a model of QSAR-2D, 3D and hybrid to predict compounds with activity to the inhibition of photosynthesis. For this, was used a data set of 44 quinoline analogues described in the literature as PET inhibitors, and all tested in the same bioassay method. For construction of models were used the programs QSAR Modeling and Pentacle. The obtained models A, C and D, were approved in the validation tests (internal and external), they are robust and with good predictive capacity. The second part of studie aimed to identify a pharmacophore model, for select compounds from the data set of first part, aiming to use as a tool for virtual screening. The research resulted in 86,560 compounds, and thus several screening filters were applied according to Briggs rule of three, in silico toxicity analyzes, unsupervised pattern recognition (PCA), and docking studies. As a result, 28 compounds remained, all of which showed potential to be herbicides, through the prediction using the obtained QSAR models, however, only the model D proved to be reliable for prediction the virtual screening. Finally, we selected the ten compounds that presented the highest predictive value of PET inhibition activity, using the model D. / A busca de novos herbicidas para o controle de ervas daninhas resistentes é necessária para atender à crescente demanda alimentar da população mundial. Este trabalho foi dividido em duas partes. A primeira teve por objetivo a obtenção de modelos de QSAR-2D, 3D e híbrido para previsão de compostos com atividade de inibição da fotossíntese. Para isso, foi utilizado um conjunto de dados formado por 44 análogos de quinolina descritos na literatura como inibidores do PET e todos testados pela mesma metodologia de ensaio biológico. Para construção dos modelos foram utilizados os programas QSAR Modeling e Pentacle. Os modelos A, C e D obtidos foram aprovados nos testes de validação (interna e externa), são robustos e com boa capacidade de previsão. A segunda parte do estudo teve como objetivo a identificação de um modelo farmacofórico, para compostos selecionados do conjunto de dados da primeira parte, visando o uso do mesmo como ferramenta para triagem virtual. A pesquisa resultou em 86.560 compostos, e assim foram aplicados diversos filtros de seleção de acordo com a regra de três de Briggs, análises “in silico” de toxicidade, técnica de reconhecimento de padrões não supervisionados (PCA), e estudos e ancoramento molecular. Como resultado, restaram 28 compostos, sendo que todos mostraram potencial para serem herbicidas, através da previsão utilizando os modelos de QSAR obtidos, porém apenas o modelo D mostrou-se confiável para previsão da triagem virtual. Por fim, foram selecionados os dez compostos que apresentaram maior valor de previsão de atividade de inibição do PET, utilizando o modelo D.

Very little is known about why and how the Parkinson's disease (PD) neurodegenerative process begins and progresses. In the course of developments for treatment of PD, the discovery of the inhibition of monoamine oxidase (MAO B) was a conceptual breakthrough, and has now been firmly established. MAO B has also been implicated in the neurodegenerative processes resulting from exposure to xenobiotic amines. For example, MAO B catalyzes the first step of the bioactivation of the parkinsonian inducing pro-neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Additional insight into the mechanism of catalysis of MAO B and the mechanism of neurotoxicity by MPTP is therefore very valuable in the pursuit of the treatment of PD. / Thesis (Ph.D. (Pharmaceutical Chemistry))--North-West University, Potchefstroom Campus, 2008.

Aquesta tesi és una continuació dels estudis iniciats en l'equip en el camp de les relacions estructura-activitat (SAR i QSAR) dels brassinoesteroides (BRs) mitjançant mètodes computacionals. L'objectiu general és centrar l'atenció en la cadena lateral, ja que la influència dels hidroxils depenia del tipus d'estudi (quantitatiu o qualitatiu) i la influència de l'extrem final de la cadena lateral era molt genèrica. El desenvolupament d'aquest objectiu principal ha portat a: 1. Estudiar les cadenes laterals d'anàlegs BRs androstànics: Basant-se en l'aproximació a l'anàleg actiu (AAA) prenent com a referència l'estructura de la brassinolida, s'ha vist que els anàlegs α-hidroxiester i α-aminoester són computacionalment bons candidats per presentar activitat brassinoesteroide. Un cop sintetitzats (en una tesi paral·lela), tres anàlegs amb la funcionalitat lliure han donat inactius mentre que quatre anàlegs amb la funcionalitat protegida han donat actius o moderadament actius. Basant-se novament en l'AAA, no ha estat possible explicar computacionalment i de forma inequívoca l'activitat i/o inactivitat d'aquests anàlegs. 2. Revisar i redefinir la conformació activa dels BRs: S'ha conclòs que la conformació activa in silico és l'anomenada HIP. Aquesta és la que explica amb més coherència la distribució tridimensional tan dels hidroxils com de l'extrem final de la cadena lateral de cara a explicar la unió de les cinc cadenes laterals tipus dels BRs amb el receptor. La raó per la qual s'han trobat diverses conformacions actives es troba en l'anàlisi conformacional dels BRs i no pas en els processos de selecció de la conformació activa. 3. Estudiar la influència de la conformació activa dels BRs sobre els models de QSAR: Conformacions actives estructuralment diferents han donat lloc a models quantitati-vament similars, però qualitativament diferents. Quantitativament similars perquè les parts dels BRs que correlacionen amb l'activitat són les mateixes. Qualitativament diferents perquè la contribució a l'activitat d'aquestes parts, especialment de cadena lateral, i la variació de la predictibilitat en funció de l'estructura són diferents en cada cas. Els models reduïts i el model HOMO han posat de manifest que no es pot extreure més informació dels models degut als desequilibris estructurals del conjunt de BRs que formen part del data set. El model a 1 μg/planta explica els requeriments estructurals que fan que un BR sigui actiu o inactiu. El model HIP explica els requeriments estructurals que determinen el grau d'activitat dels BRs actius. Fora de l'objectiu principal, però íntimament relacionat amb els estudis de QSAR s'ha volgut: 4. Determinar l'error experimental de la resposta i de les dades d'activitat: Comparant-los amb els errors dels models, s'observa que el model a 1 μg/planta està força ben ajustat i no té gaire marge de millora. En canvi, que el model HIP pot millorar considerablement sobretot en la predictibilitat, sempre i quan s'arreglin els desequilibris estructurals. D'altre banda, s'ha vist que els diferents tractaments estadístics realitzats en el bioassaig no afecten significativament al valor d'activitat. / Esta Tesis es una continuación de los estudios iniciados por el equipo en el campo de las relaciones estructura-actividad (SAR y QSAR) de los brasinoesteroides (BRs) mediante métodos computacionales. El objetivo general es centrar la atención en la cadena lateral, ya que la influencia de los hidroxilos dependía del tipo de estudio (cuantitativo o cualitativo) y la influencia del extremo final de la cadena lateral era muy genérica. El desarrollo de este objetivo principal ha llevado a: 1. Estudiar las cadenas laterales de los análogos BRs androstánicos: Basándose en la apro-ximación al análogo activo tomando como referencia la estructura de la brasinolida, se ha observado que los análogos α-hidroxiester i α-aminoester son computacionalmente buenos candidatos para presentar actividad brassinoesteroide. Una vez sintetizados (en una tesis paralela), tres análogos con la funcionalidad libre han resultado inactivos mientras que cuatro análogos con la funcionalidad protegida han resultado activos o moderadamente activos. Basándose nuevamente en la AAA, no ha sido posible explicar computacionalmente y de forma inequívoca la actividad o inactividad de estos análogos. 2. Revisar y redefinir la conformación activa de los BRs: Se ha llegado a la conclusión que la conformación activa in silico es la llamada HIP. Esta es la que explica con más coherencia la distribución tridimensional tanto de los hidroxilos como del extremo final de la cadena lateral a fin de explicar la unión de las cinco cadenas laterales tipo de los BRs con el receptor. La razón por la cual se han encontrado diversas conformaciones activas se encuentra en el análisis conformacional y no en los procesos de selección de la conformación activa. 3. Estudiar la influencia de la conformación activa de los BRs en los modelos de QSAR: Conformaciones activas estructuralmente diferentes han dado lugar a modelos cuantita-tivamente similares, pero cualitativamente diferentes. Cuantitativamente similares porque las partes de los BRs que correlacionan con la actividad son las mismas. Cualitativamente diferentes porque la contribución a la actividad de dichas partes, especialmente de la cadena lateral, y la variación de la predictibilidad en función de la estructura son diferentes en cada caso. Los modelos reducidos y el modelo HOMO han puesto de manifiesto que no se puede extraer más información de los modelos debido a los desequilibrios estructurales del conjunto de BRs que conforman el "data set". El modelo a 1 μg/planta explica los requisitos estructurales que hacen que un BR sea activo o inactivo. El modelo HIP explica los requisitos estructurales que determinan el grado de actividad de los BRs activos. Fuera del objetivo principal, pero íntimamente relacionado con los estudios de QSAR se ha querido: 4. Determinar el error experimental de la respuesta y de los datos de actividad: Compa-rándolos con los errores de los modelos, se observa que el modelo a 1 μg/planta está bastante bien ajustado y tiene poco margen de mejora. En cambio, el modelo HIP puede mejorar considerablemente sobretodo en la predictibilidad, siempre y cuando se solucionen los desequilibrios estructurales. Por otro lado, se ha observado que los diferentes tratamientos estadísticos realizados en el bioensayo no afectan significativamente al valor de actividad. / This Thesis is the continuation of the studies started by our laboratory in the field of brassinosteroids (BRs) structure activity relationships (SAR and QSAR) using computational methods. The main aim is to focus the study on the side chain, due to the influence of hydroxyl groups depends on the study (quantitative or qualitative) and the influence of the side chain end is very generic. The development of this goal has leaded to: 1. Study the side chain of androstanic BRs analogues: Based on active analogue approach (AAA) taking brassinolide as the reference structure, it has been shown that α-hydroxyester and α-aminoester analogues are computationally good candidates to elicit brassinosteroid activity. Once synthesized (in a parallel thesis), three analogues with free functionality have result inactive but four analogues with protected functionality have result active or mild active. Based once again on AAA it has not been possible explain computationally and unequivocally the activity and/or inactivity of these analogues. 2. Revise and redefine the active conformation of BRs: It has been concluded that in silico active conformation is the named as HIP. This explains more consistently the tridimensional distribution of both the hydroxyls and the end of the side chain in order to explain the union of the five side chain types with BRs receptor. The reason for having found several active conformations is in BRs conformational analysis not in the active conformation selection procedures. 3. Study the influence of BRs active conformation in QSAR models: Active conformations structurally different has lead to models which are quantitatively similar but qualitatively different. Quantitatively similar due to the parts of BRs that correlate with activity are the same. Qualitatively different due to this parts contribution, especially the side chain, and the structure depending variation of predictability are different on each model. Reduced models and HOMO model has shown that get more information from the models is not possible due to a structural imbalance in BRs data set. The 1 μg/plant model explains the structural requirements that make BRs active or inactive. The HIP model explains the structural requirements that determine the activity degree of active BRs. Out of the main aim, but close related to QSAR studies I wanted to: 4. Determine the experimental error of both the response and the activity data: Compared with models error, it is observed that the 1 μg/plant model is really well adjusted and has little improvement margin, but the HIP model can be considerably improved, overall in predictability. On the other hand, it has been shown that the different statistical treatments done in bioassay do not affect in a significant way the activity value.

The debilitating effects of spinal cord injury can be attributed to a lack of regeneration in the central nervous system. Identification of growth-promoting pathways, particularly ones that can be controlled by small molecules, could provide significant advancements in regenerative science and lead to potential treatments for spinal cord injury. The biological investigations of neuroregenerative small molecules, specifically the natural products clovanemagnolol and vinaxanthone, have been expanded to a whole organism context using the nematode Caenorhabditis elegans (C. elegans) as a tool for these studies. A straightforward assay using C. elegans was developed to screen for compounds that promote neuronal outgrowth in vivo. This outgrowth assay was then used to guide the design of chemically edited analogs of clovanemagnolol that maintained biological activity while possessing structures amenable to further modification for mechanism of action studies. Pull-down experiments using affinity reagents synthesized from a neuroactive structural derivative, clovanebisphenol, and the C. elegans proteome combined with mass spectrometry-based protein identification and genetic recapitulation using mutant C. elegans identified the putative protein target of the small molecule as a kinesin light chain, KLC-1. Furthermore, the small molecule-promoted regeneration of injured neurons in vivo was studied using laser microsurgery to cut specific axons in C. elegans followed by treatment with a library of analogs of the growth-promoting natural product vinaxanthone. Enhanced axonal regeneration was observed following small molecule treatment and the results were used to determine the structure-activity relationship of vinaxanthone, which may guide future development of potential drug candidates for the treatment of spinal cord injury. / text

Parkinson’s disease (PD) is an age-related neurodegenerative disorder. The degeneration of the neurons of the substantia nigra in the midbrain leads to the loss of dopamine from the striatum, which is responsible for the motor symptoms of PD. In the brain, the enzyme, monoamine oxidase B (MAOB), An analysis of the Lineweaver-Burk plots indicated that 7-(3-bromobenzyloxy)-3,4-dihydro-2(1H)- quinolinone inhibits MAO-B with a Ki value of 2.7 nM. An analysis of the structure-activity relationships for MAO-B inhibition shows that substitution on the C7 position of the 3,4-dihydro- 2(1H)-quinolinone moiety leads to significantly more potent inhibition compared to substitution on C6. In this regard, a benzyloxy substituent on C7 is more favourable than phenylethoxy and phenylpropoxy substitution on this position. In spite of this, C6-substituted 3,4-dihydro-2(1H)-quinolinone with potent MAO-B inhibitory activities were also identified. An analyses of selected properties of the 3,4-dihydro-2(1H)- quinolinones showed that the compounds are highly lipophilic with logP values in the range of 3.03- 4.55. LogP values between 1 and 3 are, however, in the ideal range for bioavailability. The compounds synthesised have logP values higher than 3, which may lead to lower bioavailability. Laboratory data further showed that none of the 3,4-dihydro-2(1H)-quinolinones are highly toxic to cultured cells at the concentrations, 1 μM and 10 μM, tested. For example, the most potent MAO-B inhibitor, 7-(3-bromobenzyloxy)-3,4-dihydro-2(1H)-quinolinone, reduced cell viability to 88.11% and 86.10% at concentrations of 1 μM and 10 μM, respectively. These concentrations are well above its IC50 value for the inhibition of MAO-B. At concentrations required for MAO-B inhibition, the more potent 3,4-dihydro-2(1H)-quinolinones are thus unlikely to be cytotoxic. It may thus be concluded that C7-substituted 3,4-dihydro-2(1H)-quinolinones are promising highly potent and selective MAO-B inhibitors, and thus leads for the therapy of Parkinson’s disease. represents a major catabolic pathway of dopamine. Inhibitors of MAO-B conserve the depleted supply of dopamine and are thus used in the therapy of PD. In the present study, a series of 3,4- dihydro-2(1H)-quinolinone derivatives were synthesized and evaluated as inhibitors of recombinant human MAO-A and MAO-B. These quinolinone derivatives are structurally related to a series of coumarin (1-benzopyran-2-one) derivatives, which has been reported to act as MAO-B inhibitors. C6- and C7-substituted 3,4-dihydro-2(1H)-quinolinone derivatives were synthesized by reacting 6- or 7- hydroxy-3,4-dihydro-2(1H)-quinolinone with an appropriately substituted alkyl bromide in the presence of base. To evaluate the MAO inhibitory properties (IC50 values) of the quinolinone derivatives the recombinant human MAO-A and MAO-B enzymes were used. The reversibility of inhibition of a representative 3,4-dihydro-2(1H)-quinolinone derivative was examined by measuring the recovery of enzyme activity after the dilution of the enzyme-inhibitor complexes, while the mode of MAO inhibition was determined by constructing Lineweaver-Burk plots. To determine the lipophilicity of the 3,4-dihydro-2(1H)-quinolinone derivatives, the logP values were measured. The toxicity of the 3,4-dihydro-2(1H)-quinolinone derivatives towards cultured cells (cytotoxicity) was also measured. The results document that the 3,4-dihydro-2(1H)-quinolinone derivatives are highly potent and selective MAO-B inhibitors with most homologues exhibiting IC50 values in the nanomolar range. The most potent MAO-B inhibitor, 7-(3-bromobenzyloxy)-3,4-dihydro-2(1H)-quinolinone, exhibits an IC50 value of 2.9 nM with a 2750-fold selectivity for MAO-B over the MAO-A isoform. As a MAO-B inhibitor, this compound is approximately equipotent to the most potent coumarin derivative (IC50 = 1.14 nM) reported in literature. Since MAO-B activity could be recovered after dilution of enzyme-inhibitor mixtures, it may be concluded that 7-(3-bromobenzyloxy)-3,4-dihydro-2(1H)- quinolinone is a reversible MAO-B inhibitor. The Lineweaver-Burk plots constructed for the inhibition of MAO-B by 7-(3-bromobenzyloxy)-3,4-dihydro-2(1H)-quinolinone were linear and intersected on the y-axis. These data indicated that this compound also is a competitive MAO-B inhibitor. / MSc (Pharmaceutical Chemistry), North-West University, Potchefstroom Campus, 2014

Very little is known about why and how the Parkinson's disease (PD) neurodegenerative process begins and progresses. In the course of developments for treatment of PD, the discovery of the inhibition of monoamine oxidase (MAO B) was a conceptual breakthrough, and has now been firmly established. MAO B has also been implicated in the neurodegenerative processes resulting from exposure to xenobiotic amines. For example, MAO B catalyzes the first step of the bioactivation of the parkinsonian inducing pro-neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Additional insight into the mechanism of catalysis of MAO B and the mechanism of neurotoxicity by MPTP is therefore very valuable in the pursuit of the treatment of PD. / Thesis (Ph.D. (Pharmaceutical Chemistry))--North-West University, Potchefstroom Campus, 2008.